Brief: Exagen Inc. Reports First Quarter 2023 Results
Exagen Inc XGN.O :
* . REPORTS FIRST QUARTER 2023 RESULTS
* Q1 REVENUE VIEW $9.40 MILLION -- REFINITIV IBES DATA
* Q1 REVENUE ROSE 8 PERCENT TO $11.2 MILLION
* SEES REVENUE FOR Q2 OF 2023 IN RANGE OF $10.7 MILLION TO
$11.2
MILLION
* EXAGEN - QTRLY NET LOSS PER SHARE $0.44
* Q1 EARNINGS PER SHARE VIEW $-0.56 -- REFINITIV IBES DATA
* Q2 REVENUE VIEW $10.5 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX1gJZcn
Further company coverage: XGN.O
Recent news on Exagen
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Exagen Inc. reports results for the quarter ended June 30 - Earnings Summary
Exagen Q2 revenue beats on test volume growth; raises 2026 outlook
Exagen Inc expected to post a loss of 19 cents a share - Earnings Preview
Exagen beats Q1 revenue estimates, reaffirms 2026 guidance